Published by Josh White on 13th January 2025
(Sharecast News) - Moderna slashed its 2025 revenue projection by $1bn on Monday, citing reduced demand for its Covid-19 and respiratory syncytial virus (RSV) vaccines.
URL: http://www.digitallook.com/dl/news/story/34808089/...